Instrument Inactif

Cours Amylin Pharmaceuticals LLC

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2012	Wall Street termine sans grande tendance après les PMI	RE
2012	Le laboratoire Bristol-Myers lance une OPA amicale sur Amylin	RE

Wall Street termine sans grande tendance après les PMI	02/07/12	RE
Le laboratoire Bristol-Myers lance une OPA amicale sur Amylin	30/06/12	RE
Merck & Co., Inc. : Sanofi et Merck interessés par Amylin-Bloomberg	25/05/12	RE

Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	09/08/12
Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	02/08/12
BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	16/07/12
GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	16/07/12
GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	15/07/12

Secteur

	Varia. 1 janv.	Capi.
CSL LIMITED	-3,53%	87,17 Md
SAMSUNG BIOLOGICS CO.,LTD.	+1,97%	40,1 Md
UCB	+56,59%	25,12 Md
BIOMARIN PHARMACEUTICAL INC.	-14,82%	15,59 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-8,82%	12 Md
INCYTE CORPORATION	-16,29%	11,8 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41,58%	11,8 Md
SWEDISH ORPHAN BIOVITRUM AB	+6,14%	8,81 Md
INNOVENT BIOLOGICS, INC.	-9,59%	8,24 Md